Cargando…
Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030463/ https://www.ncbi.nlm.nih.gov/pubmed/27528461 http://dx.doi.org/10.1038/mp.2016.140 |
| _version_ | 1782454684434300928 |
|---|---|
| author | Fava, M Johe, K Ereshefsky, L Gertsik, L G English, B A Bilello, J A Thurmond, L M Johnstone, J Dickerson, B C Makris, N Hoeppner, B B Flynn, M Mischoulon, D Kinrys, G Freeman, M P |
| author_facet | Fava, M Johe, K Ereshefsky, L Gertsik, L G English, B A Bilello, J A Thurmond, L M Johnstone, J Dickerson, B C Makris, N Hoeppner, B B Flynn, M Mischoulon, D Kinrys, G Freeman, M P |
| author_sort | Fava, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5030463 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50304632016-09-29 Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients Fava, M Johe, K Ereshefsky, L Gertsik, L G English, B A Bilello, J A Thurmond, L M Johnstone, J Dickerson, B C Makris, N Hoeppner, B B Flynn, M Mischoulon, D Kinrys, G Freeman, M P Mol Psychiatry Erratum Nature Publishing Group UK 2016-08-16 2016 /pmc/articles/PMC5030463/ /pubmed/27528461 http://dx.doi.org/10.1038/mp.2016.140 Text en © The Author(s) 2016 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Erratum Fava, M Johe, K Ereshefsky, L Gertsik, L G English, B A Bilello, J A Thurmond, L M Johnstone, J Dickerson, B C Makris, N Hoeppner, B B Flynn, M Mischoulon, D Kinrys, G Freeman, M P Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients |
| title | Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients |
| title_full | Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients |
| title_fullStr | Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients |
| title_full_unstemmed | Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients |
| title_short | Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients |
| title_sort | erratum: a phase 1b, randomized, double blind, placebo controlled, multiple-dose escalation study of nsi-189 phosphate, a neurogenic compound, in depressed patients |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030463/ https://www.ncbi.nlm.nih.gov/pubmed/27528461 http://dx.doi.org/10.1038/mp.2016.140 |
| work_keys_str_mv | AT favam erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT johek erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT ereshefskyl erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT gertsiklg erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT englishba erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT bilelloja erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT thurmondlm erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT johnstonej erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT dickersonbc erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT makrisn erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT hoeppnerbb erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT flynnm erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT mischoulond erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT kinrysg erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients AT freemanmp erratumaphase1brandomizeddoubleblindplacebocontrolledmultipledoseescalationstudyofnsi189phosphateaneurogeniccompoundindepressedpatients |